Recombinant immunotoxin induces tumor intrinsic STING signaling against head and neck squamous cell carcinoma
Abstract The innate immune stimulator of interferon genes (STING) pathway is known to activate type I interferons (IFN-I) and participate in generating antitumor immunity. We previously produced hDT806, a recombinant diphtheria immunotoxin, and demonstrated its efficacy against head and neck squamou...
Main Authors: | Guiqin Xie, Liang Shan, Cuicui Yang, Yuanyi Liu, Xiaowu Pang, Shaolei Teng, Tzyy-Choou Wu, Xinbin Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-45797-7 |
Similar Items
-
Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
by: Guiqin Xie, et al.
Published: (2022-03-01) -
Development of Recombinant Immunotoxins for Hairy Cell Leukemia
by: Robert J. Kreitman, et al.
Published: (2020-08-01) -
Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
by: Brendan L. Hagerty, et al.
Published: (2020-06-01) -
Evaluation of Hydra HALT-1 as a toxin moiety for recombinant immunotoxin
by: William F. Jiemy, et al.
Published: (2020-06-01) -
Evaluation of Vertebrate-Specific Replication-Defective Zika Virus, a Novel Single-Cycle Arbovirus Vaccine, in a Mouse Model
by: Shengfeng Wan, et al.
Published: (2021-04-01)